Deciphering Graphene-Homocysteine Interactions via Density Functional Theory: Impact on Platelet Function through an

Abhishek Ramachandra Panigrahi1, Ritika Yadav1, Rimika Roy1

  • 1Department of Zoology, School of Basic Sciences, Central University of Punjab, Ghudda, Bathinda, Punjab 151401, India.

The biomedical usefulness of graphene materials depends on their stability in blood and how they interact with plasma biomolecules. In circulation, they can bind to fibrinogen, platelets, and lipids, key players in thrombosis, potentially influencing coagulation and thrombotic risk. Homocysteine (Hcy), a sulfur-containing amino acid associated with cardiovascular disorders, plays a crucial role in platelet activation and oxidative stress, yet its interaction with graphene derivatives remains poorly understood. Given the experimental complexity of systematically screening graphene derivatives for their interactions with Hcy, computational modeling and simulations offer an efficient and reliable strategy to predict binding behavior, elucidate electronic interactions, and prioritize candidates for experimental validation. Among available computational approaches, density functional theory (DFT) provides one of the most powerful models to investigate these interactions at the molecular level. In this study, we employed DFT simulations to explore the molecular interactions between Hcy and graphene derivatives, providing insights into their electronic and structural modifications. DFT results revealed that graphene oxide (GO) interacts more strongly than pristine and amine-functionalized graphene. As their interaction might influence hemostasis and thrombosis, the effect of the GO-Hcy conjugate on blood platelet functional parameters, key events of hemostasis, was explored. The GO-Hcy conjugate promoted platelet activation and aggregation. XPS and zeta-potential analyses verified successful Hcy conjugation to GO, yielding a more negative surface charge that may influence its thrombogenicity. These results underscore the importance of graphene interactions with thrombotic components and support the design of graphene-based materials with improved biocompatibility and controlled thrombogenic responses.

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
6.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.5K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.9K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.9K